Monetising A Vaccine Shows What It’s Really All About.

LOADSAMONEY! According to the sales pitch on Thursday from investment banks Credit Suisse and Morgan Stanley, a COVID-19 vaccine could be a “bumper revenue opportunity“, projected to earn at least $10 billion a year. Morgan Stanley’s projection is at least $10 billion a year across developed countries but Credit Suisse is bigging it up further […]

Read More…


An antiviral maybe but a vaccine isn’t needed and wouldn’t be effective.

Apparently everything now hangs on a vaccine: stockmarkets rise and fall on the mere rumour of how the rumoured development of a particular rumoured COVID-19 vaccine is going; politicians say that normality can’t be resumed until a vaccine is available; people are fed the line that a virus must have a vaccine and that without […]

Read More…


Testing more people means cases of ‘new’ infections will rise, except they are not ‘new’.

The more tests you undertake, the higher the number of positive results you will get.  Except of course ‘positive tests’ mean very little, something we have written about previously here but find ourselves referring back to as it explains the apparent rise in cases of ‘the coronavirus’.  Nucelic acid testing, undertaken principally through RT-PCR analysis […]

Read More…